Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   


CRRD ID: 3427
Species: Rattus norvegicus
CRRD Object: Gene
Symbol: Psmb9
Name: proteasome 20S subunit beta 9
Acc ID: CHEBI:27899
Term: cisplatin
Definition: A diamminedichloroplatinum compound in which the two ammine ligands and two chloro ligands are oriented in a cis planar configuration around the central platinum ion. An anticancer drug that interacts with, and forms cross-links between, DNA and proteins, it is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary. Commonly but incorrectly described as an alkylating agent due to its mechanism of action (but it lacks alkyl groups).
Chemical ID: MESH:D002945
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
QualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
decreases response to substanceISORGD:7372196480464CTDPSMB9 mRNA results in decreased susceptibility to Cisplatin

increases expressionISORGD:7372196480464CTDCisplatin results in increased expression of PSMB9 mRNA

PMID:23165153, PMID:27392435, PMID:27594783
multiple interactionsISORGD:7372196480464CTD[Cisplatin co-treated with jinfukang] results in increased expression of PSMB9 mRNA

Go Back to source page   Continue to Ontology report


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.